Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 05/25 10:00:00 pm
118.6 USD   +0.68%
05/24 VERTEX PHARMACE : Sports shorts
05/22 VERTEX PHARMACE : VRTX) Files An 8-K Other Events
05/19 VERTEX PHARMACE : Awards 40 Scholarships Totaling $200,000 to People..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 2 150 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals1,032100%1,702100% +64.89%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States763.3273.9%1,32277.7% +73.17%
Europe219.6021.3%320.4618.8% +45.93%
Other49.424.8%59.913.5% +21.22%
Managers
NameAgeSinceTitle
Jeff Leiden612009Chairman, President & Chief Executive Officer
Ian F. Smith512001EVP, Chief Operating & Financial Officer
Jeffrey A. Chodakewitz, MD612014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD522012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD661989Director
Bruce I. Sachs, MBA571998Lead Independent Director
Elaine S. Ullian691997Lead Independent Director
Margaret G. McGlynn, MBA572011Independent Director
Terrence C. Kearney, MBA622011Independent Director
Yuchun Lee, MBA512012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 249,068,782 247,237,610 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 22,978,643 9.23%
Capital Research & Management Co. (World Investors) 17,900,933 7.19%
Wellington Management Co. LLP 17,765,933 7.13%
Fidelity Management & Research Co. 17,498,169 7.03%
The Vanguard Group, Inc. 16,474,890 6.62%
BlackRock Fund Advisors 13,475,197 5.41%
SSgA Funds Management, Inc. 12,013,178 4.82%
ClearBridge Investments LLC 8,754,618 3.52%
Columbia Management Investment Advisers LLC 7,307,360 2.93%
JPMorgan Investment Management, Inc. 6,721,989 2.70%
Holdings
NameEquities%Valuation
Crispr Therapeutics AG (CRSP) 3,186,5867.92%54,235,694 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..59.90%29 624
AMGEN, INC.5.74%112 531
CELGENE CORPORATION1.35%90 349
GILEAD SCIENCES, INC.-10.19%84 101
REGENERON PHARMACEUTIC..25.68%48 999
ACTELION LTD24.49%30 824
GENMAB A/S17.82%12 903
TESARO INC15.80%8 320
BIOVERATIV INC0.00%5 934
EXELIXIS, INC.35.28%5 645
NEUROCRINE BIOSCIENCES..38.32%4 724
HUALAN BIOLOGICAL ENGI..--.--%4 701
TONGHUA DONGBAO PHARMA..-4.70%4 405
KITE PHARMA INC58.25%4 047
BLUEBIRD BIO INC30.23%3 233
CHINA BIOLOGIC PRODUCT..6.01%3 059
PEPTIDREAM INC0.99%3 046
BIOCON LTD-0.54%3 037
INTERCEPT PHARMACEUTIC..3.99%2 844
BEIJING SL PHARMACEUTI..--.--%2 566
JUNO THERAPEUTICS INC31.57%2 554
Sector Bio Therapeutic Drugs
Vertex Pharmaceuticals Inc : Connections
SimpliVity Corp.
The Alliance for Business Leadership
The American Institute of Certified Public Accountants
The Brigham & Women's Hospital, Inc.
Institute of Chartered Accountants in England & Wales
Massachusetts Life Sciences Center
The Financial Executives Institute
OneCloud Software, Inc.
Massachusetts Mutual Life Insurance Co.
The Hastings Center
Infectious Diseases Society of America
WGBH Educational Foundation
The American Society for Clinical Pharmacology & Therapeutics
Accelerated Cure Project for Multiple Sclerosis
Vertex Pharmaceuticals
GreatCall, Inc.
New England Aquarium Corp.
American Academy of Arts & Sciences
Massachusetts Institute of Technology
ActivBiotics, Inc.
The Broad Institute, Inc.
Massachusetts Life Sciences Collaborative
Whitehead Institute for Biomedical Research
Museum of Science
American Society for Clinical Investigation
Massachusetts Workforce Board Association
The Boston Private Industry Council, Inc.
Nantero, Inc.
Institute of Medicine
SpiderCloud Wireless, Inc.
Macp Organization
DataGravity, Inc.
Charles River Ventures, Inc.
Jibo, Inc.
National Academy of Sciences
iControl Networks, Inc.
Clarabridge, Inc.
Biotechnology Innovation Organization
Association of American Physicians
Abington Friends School
Alkeus Pharmaceuticals, Inc.
New England Healthcare Institute
Orphan Technologies Ltd.
Harvard Medical School
Wesleyan University
Allego, Inc.
Celebrity Series of Boston, Inc.
General Catalyst Partners LLC
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem